FAQ about TTEA and
How does antiretroviral therapy stop HIV
The amount of virus present in bodily fluids (commonly measured
with the plasma viral load assay) is the critical determinant of
the likelihood of HIV transmission. The more HIV present, the higher
the plasma viral load, and the higher the likelihood of HIV transmission
Antiretroviral therapy suppresses the amount of
virus in the body, and the plasma viral load is therefore driven
to undetectable levels — dramatically reducing the probability
that the infected individual under treatment will pass on the virus
Are there any side effects associated
ART may have side effects, but they typically are easy to identify
with appropriate monitoring and are readily treatable. Also, there
are currently more than 30 different drugs in six drug classes with
additional new classes of drugs under development, according to
a Food and Drug Administration fact sheet issued January 6, 2010. While
all of them have some side effects, people experience the drugs
differently. And there are two or three choices of first- and second-line
regimens so that we can be confident that most people will find
the drugs acceptable.
Will test-and-treat replace current strategies
used in HIV management?
No. Traditional prevention methods complement and strengthen test-and-treat.
Male circumcision should significantly reduce transmission, and
behavior change, couples counseling, condom promotion, partner reduction,
treatment of sexually transmitted infections, and vaccine and microbicide
development should all continue.